On the other hand, the action of DHT is blocked by RGD peptide which blocks the binding site on integrin αvβ3 in ER-α-negative MDA-MB-231 breast cancer cells which contain ER-α36 and GPR30 [13]. This evidence concerns the gene GPER1 and breast cancer.